A detailed history of Parallel Advisors, LLC transactions in Teladoc Health, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 1,359 shares of TDOC stock, worth $12,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,359
Previous 2,279 40.37%
Holding current value
$12,951
Previous $22,000 45.45%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.79 - $10.09 $6,246 - $9,282
-920 Reduced 40.37%
1,359 $12,000
Q2 2024

Aug 08, 2024

BUY
$9.65 - $15.06 $1,080 - $1,686
112 Added 5.17%
2,279 $22,000
Q1 2024

May 06, 2024

SELL
$14.39 - $22.03 $26,923 - $41,218
-1,871 Reduced 46.33%
2,167 $32,000
Q4 2023

Feb 09, 2024

BUY
$15.57 - $22.1 $8,018 - $11,381
515 Added 14.62%
4,038 $87,000
Q3 2023

May 20, 2024

SELL
$18.53 - $29.77 $4,817 - $7,740
-260 Reduced 6.87%
3,523 $65,000
Q3 2023

Nov 13, 2023

SELL
$18.53 - $29.77 $4,817 - $7,740
-260 Reduced 6.87%
3,523 $65,000
Q2 2023

May 20, 2024

BUY
$22.42 - $28.17 $1,233 - $1,549
55 Added 1.48%
3,783 $95,000
Q2 2023

Aug 04, 2023

BUY
$22.42 - $28.17 $1,233 - $1,549
55 Added 1.48%
3,783 $95,000
Q1 2023

May 20, 2024

BUY
$22.27 - $33.2 $34,763 - $51,825
1,561 Added 72.04%
3,728 $96,000
Q1 2023

Apr 25, 2023

BUY
$22.27 - $33.2 $70,217 - $104,679
3,153 Added 548.35%
3,728 $96,000
Q4 2022

Feb 03, 2023

SELL
$22.83 - $33.31 $27,943 - $40,771
-1,224 Reduced 68.04%
575 $13,000
Q3 2022

Nov 10, 2022

BUY
$25.35 - $43.66 $5,931 - $10,216
234 Added 14.95%
1,799 $46,000
Q2 2022

Aug 01, 2022

BUY
$28.63 - $75.86 $26,454 - $70,094
924 Added 144.15%
1,565 $52,000
Q1 2022

Apr 28, 2022

SELL
$50.79 - $95.08 $24,125 - $45,163
-475 Reduced 42.56%
641 $47,000
Q4 2021

Jan 20, 2022

SELL
$87.43 - $154.29 $60,588 - $106,922
-693 Reduced 38.31%
1,116 $102,000
Q3 2021

Nov 02, 2021

SELL
$125.92 - $164.64 $422,083 - $551,873
-3,352 Reduced 64.95%
1,809 $229,000
Q2 2021

Aug 06, 2021

SELL
$132.71 - $192.38 $122,491 - $177,566
-923 Reduced 15.17%
5,161 $858,000
Q1 2021

Apr 23, 2021

SELL
$171.3 - $294.54 $153,656 - $264,202
-897 Reduced 12.85%
6,084 $1.11 Million
Q4 2020

Feb 02, 2021

BUY
$172.44 - $231.8 $429,548 - $577,413
2,491 Added 55.48%
6,981 $1.4 Million
Q3 2020

Oct 27, 2020

SELL
$183.75 - $249.42 $4,961 - $6,734
-27 Reduced 0.6%
4,490 $984,000
Q2 2020

Jul 16, 2020

BUY
$139.1 - $204.94 $14,049 - $20,698
101 Added 2.29%
4,517 $862,000
Q1 2020

Apr 27, 2020

BUY
$82.96 - $167.44 $311,763 - $629,239
3,758 Added 571.12%
4,416 $684,000
Q4 2019

Jan 30, 2020

BUY
$61.54 - $85.88 $615 - $858
10 Added 1.54%
658 $55,000
Q3 2019

Nov 01, 2019

SELL
$55.3 - $72.2 $5,640 - $7,364
-102 Reduced 13.6%
648 $44,000
Q2 2019

Aug 05, 2019

BUY
$49.86 - $66.41 $30,514 - $40,642
612 Added 443.48%
750 $50,000
Q1 2019

May 01, 2019

BUY
$46.23 - $69.99 $6,009 - $9,098
130 Added 1625.0%
138 $8,000
Q3 2018

Nov 01, 2018

BUY
$59.4 - $86.35 $475 - $690
8 New
8 $1,000
Q3 2017

Nov 14, 2017

SELL
$28.95 - $37.0 $7,063 - $9,028
-244 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
244
244 $8,000

Others Institutions Holding TDOC

About Teladoc Health, Inc.


  • Ticker TDOC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 162,196,000
  • Market Cap $1.55B
  • Description
  • Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health cond...
More about TDOC
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.